Geraldine Henwood, President and CEO at Baudax Bio, Inc. (BXRX), bought 8,200 shares at $0.59 ($5K) on 2021-09-22, disclosed to the SEC on 2021-09-23.
Open-market purchase of $5k BXRX by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| REPH | SELL | 2020-04-20 | $658K | — | Filing → |
| REPH | SELL | 2019-05-15 | $1.5M | — | Filing → |
| REPH | BUY | 2015-06-09 | $40K | — | Filing → |